Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Obstructive Sleep Apnea Syndrome
NCT00669695Phase 2Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- May 2008
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of atorvastatin in obstructive sleep apnea syndrome (OSAS), sponsored by CHU Grenoble Alpes. Started May 2008; status: terminated.
02
Drugs
atorvastatin
03
Conditions
obstructive sleep apnea syndrome (OSAS)
Beyond the preview
Go deeper on NCT00669695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669695.